SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107449

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107449

U.K. Drug for Abuse Testing Devices Market, By Product Type, By Sample Type, By End User, By Geography

PUBLISHED:
PAGES: 258 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

U.K. Drug for Abuse Testing Devices Market is estimated to be valued at USD 269.6 Mn in 2026 and is expected to reach USD 387.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 269.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.10% 2033 Value Projection: USD 387.7 Mn

Drug for abuse are illegal drugs consumed for the non-medication purpose for longer period of time. Drugs of abuse testing is performed both for medical purposes and legal causes such as workplace drug testing. The test for drug for abuse include immunoassay to screen different samples and the confirmation of screening results by definitive analytical techniques such as spectrometry and chromatography. Illicit drugs include cocaine, amphetamines, heroin, and hallucinogens are substances that can inhibit the central nervous system and cause hallucinogenic effects. The key end users in drug for abuse testing market include hospitals, diagnostic laboratories, federal departments, and rehabilitation centers. Some of the other end users are academic institutes and research laboratories.

Market Dynamics

The increasing production and trade of illicit drugs, rise in road accidents and death rates, increase in the consumption of illegal drugs, and growing government initiatives to reduce the incidence of driving under influence of drugs and alcohol are the factors that are driving growth of the market. For instance, according to data by the National Health Services, the number of hospital admissions in England for heroin or other opioid poisoning increased by 121%, since the past 12 years (2006-2018). The number of patients were around 7,258 in the year 2017-2018. Furthermore, According to the press release by Gov. UK in July 2017, the Home Secretary has launched the government's new drug strategy, to reduce illicit drug use and increase the rate of individuals recovering from drug dependence. The new strategy confronts these threats and sets out new action to protect the most vulnerable, including the homeless, victims of domestic abuse and those with mental health issues.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.K. drug for abuse testing device market based on the following parameters - Company Highlights, Product Types Portfolio, Key Highlights, Financial Performance, and Market Strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc, Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.K. drug for abuse testing device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.K. drug for abuse testing device market

Market Segmentation

  • By Product Type (Revenue, USD Mn, 2021-2033)
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breathalyzers
    • Semiconductor-based Breathalyzer
    • Infrared (IR) Based Breathalyzer
    • Fuel Cell-based Breathalyzer
  • Oral Fluid Testing Devices
  • Urine Testing Devices
    • Drug Testing Cup
    • DIP Cards
    • Drug Testing Cassettes
  • Consumables
    • Assay Kits
    • Calibrators and Controls
    • Others
  • By Sample Type (Revenue, USD Mn, 2021-2033)
  • Urine
  • Breathe
  • Saliva
  • Hair
  • Others
  • By End User (Revenue, USD Mn, 2021-2033)
  • Hospitals
  • Federal Departments
  • Rehabilitation Centers
  • Diagnostic Laboratories
  • Academic Institutes and Research Centers
  • Others
  • Key Players
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc
  • Dragerwerk AG & Co. KGaA
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
  • Alfa Scientific Designs, Inc
  • Lifeloc Technologies Inc
  • Lion Laboratories Limited
  • OraSure Technologies, Inc
  • Omega Laboratories, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Hoffmann-La Roche AG
  • Premier Biotech, Inc
  • Psychemedics Corporation
  • Innovative Testing Solutions
  • Biopanda Reagents Ltd
  • Alpha Laboratories
  • Matrix Diagnostics
  • Atlas Medical
  • Rapid Labs Limited
  • Randox Laboratories Ltd.
Product Code: CMI4439

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sample Type
    • Market Snapshot, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PORTER'S Five Forces Analysis
  • Technological Advancements
  • Product Launch/ Approvals
  • Merger-Acquisition Scenario
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Market Breakthrough Products
  • Pricing Analysis
  • Innovative Technologies for Fake Urine Detection

4. U.K. Drug for Abuse Testing Devices Market, By Product Type, 2021-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Immunoassay Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Chromatography Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Breathalyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Semiconductor-based Breathalyzer
      • Infrared (IR) Based Breathalyzer
      • Fuel Cell-based Breathalyzer
  • Oral Fluid Testing Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Urine Testing Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Drug Testing Cups
      • DIP Cards
      • Drug Testing Cassettes
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
      • Assay Kits
      • Calibrators and Controls
      • Others

5. U.K. Drug For Abuse Testing Devices Market, By Sample Type, 2021-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Urine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Breathe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Saliva
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. U.K Drug For Abuse Testing Device Market, By End User, 2021-2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Federal Departments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Rehabilitation Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Academic Institutes and Research Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Abbott Laboratories
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dragerwerk AG & Co. KGaA
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Laboratory Corporation of America Holdings
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Quest Diagnostics
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alfa Scientific Designs, Inc
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lifeloc Technologies Inc.
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lion Laboratories Limited
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • OraSure Technologies, Inc.
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Omega Laboratories, Inc.
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Shimadzu Corporation
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Siemens Healthineers
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hoffmann-La Roche AG
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Premier Biotech, Inc..
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Psychemedics Corporation
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Innovative Testing Solutions
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biopanda Reagents Ltd
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alpha Laboratories
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Matrix Diagnostics
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Atlas Medical
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Rapid Labs Limited
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Randox Laboratories Ltd.
      • Company Highlights
    • Product Types Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!